Placebo + AZD3480 + AZD3480
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout Placebo + AZD3480 + AZD3480
Placebo + AZD3480 + AZD3480 is a phase 2 stage product being developed by AstraZeneca for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT00683462. Target conditions include ADHD.
What happened to similar drugs?
10 of 20 similar drugs in ADHD were approved
Approved (10) Terminated (2) Active (10)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00683462 | Phase 2 | Completed |
Competing Products
20 competing products in ADHD